Legal Representation
Attorney
Danny M. Awdeh
USPTO Deadlines
Next Deadline
1822 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250121)
Due Date
January 21, 2031
Grace Period Ends
July 21, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 21, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 21, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 3, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 3, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 27, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 5, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 16, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 16, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 16, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 30, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| May 30, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Mar 15, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 15, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 15, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 13, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 31, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 1, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development of pharmaceuticals for the treatment of arrhythmogenic cardiomyopathy; medical and scientific research services in the field of arrhythmogenic cardiomyopathy; compiling patient data for research purposes in the field of pharmaceutical research and development for the treatment of arrhythmogenic cardiomyopathy
First Use Anywhere:
Jan 12, 2023
First Use in Commerce:
Jan 12, 2023
Class 044
Providing information in the field of the diagnosis and treatment of arrhythmogenic cardiomyopathy; providing information in the field of arrhythmogenic cardiomyopathy; Providing links to the web sites of others featuring information about arrhythmogenic cardiomyopathy; providing links to the web sites of others in the field of the diagnosis and treatment of arrhythmogenic cardiomyopathy
First Use Anywhere:
Jan 12, 2023
First Use in Commerce:
Jan 12, 2023
Additional Information
Pseudo Mark
PEGASUS ARRHYTHMOGENIC CARDIOMYOPATHY
Classification
International Classes
042
044